[HTML][HTML] An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes
Abstract Type 2 diabetes (T2D), a chronic metabolic disease characterized by
hyperglycemia, results in significant disease burden and financial costs globally. Whilst the …
hyperglycemia, results in significant disease burden and financial costs globally. Whilst the …
An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes.
A Mahboob, DKL Senevirathne, P Paul… - … Journal of Biological …, 2022 - europepmc.org
Type 2 diabetes (T2D), a chronic metabolic disease characterized by hyperglycemia, results
in significant disease burden and financial costs globally. Whilst the majority of T2D cases …
in significant disease burden and financial costs globally. Whilst the majority of T2D cases …
[PDF][PDF] An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes
A Mahboob, DKL Senevirathne, P Paul… - … Journal of Biological …, 2023 - researchgate.net
ABSTRACT Type 2 diabetes (T2D), a chronic metabolic disease characterized by
hyperglycemia, results in significant disease burden and financial costs globally. Whilst the …
hyperglycemia, results in significant disease burden and financial costs globally. Whilst the …
An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes.
A Mahboob, DKL Senevirathne, P Paul, F Nabi… - 2023 - cabidigitallibrary.org
Abstract Type 2 diabetes (T2D), a chronic metabolic disease characterized by
hyperglycemia, results in significant disease burden and financial costs globally. Whilst the …
hyperglycemia, results in significant disease burden and financial costs globally. Whilst the …
An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes
A Mahboob, DKL Senevirathne… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Type 2 diabetes (T2D), a chronic metabolic disease characterized by hyperglycemia, results
in significant disease burden and financial costs globally. Whilst the majority of T2D cases …
in significant disease burden and financial costs globally. Whilst the majority of T2D cases …